With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma||University of California San Francisco / Zulekha Qadeer, PhD||Young Investigator Grants||2019||California|
|A comprehensive public resource for fusion-negative sarcoma sequencing data||University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD||Crazy 8 Pilots||2019||California|
|Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa||Baylor College of Medicine / Mark Zobeck, MD, PhD||Psychosocial Launch Grant||2019||Texas|
|Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion||Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD||Reach Grants||2019||Ohio|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD||Crazy 8 Pilots||2019||New York|
|Targeted Hyperactivation of PI3K/AKT in B-cell malignancies||Dana-Farber Cancer Institute / Vishal Khairnar, PhD||Young Investigator Grants||2019||Massachusetts|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD||Innovation Grants||2019||Massachusetts|